Form 4 for CHE CHEMED CORP
Accepted 2026-08-06 14:17:09 ET · period of report 2026-08-05 · accession 0001193125-26-337649 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-06 14:17 | 2026-08-05 | CHE | Wherley Joel L | CEO - Vitas Healthcare | M - OptEx | $445.35 | +2,599 | 3,451 | +305% | +$1.16M |
| D | 2026-08-06 14:17 | 2026-08-05 | CHE | Wherley Joel L | CEO - Vitas Healthcare | F - Tax | $542.62 | -2,270 | 1,181 | -66% | -$1.23M |
| D | 2026-08-06 14:17 | 2026-08-05 | CHE | Wherley Joel L | CEO - Vitas Healthcare | M - OptEx | $445.35 | -2,599 | 30.2K | -8% | -$1.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Capital Stock | 2026-08-05 | M | A | 2,599 | $445.35 | 3,451 | D | — | — | |
| 2 | Common | Capital Stock | 2026-08-05 | F | D | 2,270 | $542.62 | 1,181 | D | — | — | (F1) Payment of purchase price and tax obligation on stock option exercise. |
| 3 | Derivative | Stock Option (right to buy with tandem tax withholding) | 2026-08-05 | M | D | 2,599 | $445.35 | 30,220 | D | $445.35 · — to 2026-10-28 | 2,599 Capital Stock | (F2) Vesting in three equal annual installments commencing 10/28/2022. |